11
Jan

Shire has struck a deal to buy NPS Pharma and its rare disease drug portfolio for $46 a share, or $5.2 billion, making headlines for its go-it-alone strategy on the eve of the big JP Morgan conference in San Francisco.

…read more

Source: UPDATED: Shire nabs NPS’s rare disease drug portfolio in $5.2B buyout

    

0 No comments